Staging of brain pathology related to sporadic Parkinson's disease

Neurobiology of Aging

Volumn 24, Issue 2, 2003, Pages 197-211

  Braak, Heiko ^a   Del Tredici, Kelly ^a   Rüb, Udo ^a   De Vos, Rob A I ^b   Jansen Steur, Ernst N H ^b   Braak, Eva ^a  

^a GOETHE UNIVERSITY   (Germany)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

synuclein; Lewy bodies; Lewy neurites; Limbic system; Motor system; Parkinson's disease; Staging procedure

Indexed keywords

ALPHA SYNUCLEIN;

AGED; ARTICLE; ASSOCIATION CORTEX; BRAIN CORTEX; BRAIN STEM; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLOSSOPHARYNGEAL NERVE; GRAY MATTER; HUMAN; HUMAN TISSUE; LEWY BODY; MAJOR CLINICAL STUDY; MALE; MOTONEURON NUCLEUS; NEOCORTEX; NERVE CELL; NEURITE; NEUROPATHOLOGY; OLFACTORY NUCLEUS; PARKINSON DISEASE; PREFRONTAL CORTEX; PREMOTOR CORTEX; PRIORITY JOURNAL; STAGING; TEMPORAL CORTEX; VAGUS NERVE;

AGED; AGED, 80 AND OVER; BRAIN; FEMALE; HUMANS; LEWY BODIES; LEWY BODY DISEASE; MALE; MEDULLA OBLONGATA; NEOCORTEX; PARKINSON DISEASE; TEMPORAL LOBE;

EID: 0037333666     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00065-9     Document Type: Article

References (72)

1. Baba M., Nakajo S., Tu P.H., Tomita T., Nakaya K., Lee V.M.Y.et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152:1998;879-884.
2. Bergeron C, Pollanen MS. Pathogenesis of the Lewy body. In: Perry RH, McKeith IG, Perry EK, editors. Dementia with Lewy bodies. Cambridge, NY: Cambridge University Press, 1996. p. 302-7.
3. Braak E., Braak H. Silver staining method for demonstrating Lewy bodies in Parkinson's disease and argyrophilic oligodendrocytes in multiple system atrophy. J. Neurosci. Methods. 87:1999;111-115.
4. Braak H. Architectonics as seen by lipofuscin stains. In: Jones EG, Peters A, editors. Cerebral Cortex. Cellular Components of the Cerebral Cortex, vol. 1. London: Plenum Press, 1984. p. 59-104.
5. Braak H., Braak E. Nuclear configuration and neuronal types of the nucleus niger in the brain of the human adult. Hum. Neurobiol. 5:1986;71-82.
6. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
7. Braak H., Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol. 1:1991;213-216.
8. Braak H., Braak E. The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci. Res. 15:1992;6-31.
9. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging. 18:1997;351-357.
10. Braak H., Braak E. Pathoanatomy of Parkinson's disease. J. Neurol. 247(Suppl 2):2000;3-10.
11. Braak H., Braak E., Yilmazer D., de Vos R.A.I., Jansen Steur E.N.H., Bohl J.et al. Amygdala pathology in Parkinson's disease. Acta Neuropathol. 88:1994;493-500.
12. Braak H, Braak E, Yilmazer D, Schultz C, Bohl J. Age-related changes of the human cerebral cortex. In: Cruz-Sanchez FF, Ravid R, Cuzner ML, editors. Neuropathological Diagnostic Criteria for Brain Banking. Biomedical Health Research, vol. 10. Amsterdam: IOS Press 1995;19:14-9.
13. Braak H., Rüb U., Sandmann-Keil D., Gai W.P., de Vos R.A.I., Jansen Steur E.N.H.et al. Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol. 99:2000;489-495.
14. Braak H., Del Tredici K., Bohl J., Bratzke H., Braak E. Pathological changes in the parahippocampal region in select non-Alzheimer dementias. Ann. N. Y. Acad. Sci. 911:2000;221-239.
15. Braak H., Del Tredici K., Gai W.P., Braak E. Alpha-synuclein is not a requisite component of synaptic boutons in the adult human central nervous system. J. Chem. Neuroanat. 20:2000;245-252.
16. Calne D.B., Snow B.J., Lee C. Criteria for diagnosing Parkinson's disease. Ann. Neurol. 32:1992;125-127.
17. Cochran W.G. Some methods for strengthening the common c2-tests. Biometrics. 10:1954;417-451.
18. Dale G.E., Probst A., Luthert P., Anderton B.H., Leigh P.N. Relationship between Lewy bodies and pale bodies in Parkinson's disease. Acta Neuropathol. 83:1993;525-529.
19. Damier P., Hirsch E.C., Agid Y., Graybiel A.M. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D28K immunohistochemistry. Brain. 122:1999;1421-1436.
20. Damier P., Hirsch E.C., Agid Y., Graybiel A.M. The substantia nigra of the human brain. II. Patterns of loss of dopaminergic neurons in Parkinson's disease. Brain. 122:1999;1437-1448.
21. Delwaide P.J., Pepin J.L., Maertens de Noordhout A. The audiospinal reaction in parkinsonian patients reflects functional changes in reticular nuclei. Ann. Neurol. 33:1993;63-69.
22. de Vos R.A.I., Jansen Steur E.N.H., Stam F.C., Ravid R., Swaab D. Lewy body disease: clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia. Clin. Neurol. Neurosurg. 97:1995;13-22.
23. De Vos RAI, Jansen Steur ENH, Yilmazer D, Braak H, Braak E. Pathological and clinical features of Parkinson's disease with and without dementia. In: Perry RH, McKeith IG, Perry EK, editors. Dementia with Lewy Bodies. Cambridge, NY: Cambridge University Press, 1996. p. 255-267.
24. de Vos RAI, Jansen Steur ENH, Yilmazer D, Braak H, Braak E. Pathological and clinical features of Parkinson's disease with and without dementia. In: Perry RH, McKeith IG, Perry EK, editors. Dementia with Lewy bodies. Cambridge, NY: Cambridge University Press, 1996. p. 255-67 [23a] Del Tredici K., Rüb U., de Vos R.A.I., Bohl J.R.E., Braak H. Where does Parkinson disease pathology begin in the brain? J. Neuropathol. Exp. Neurol. 61:2002;413-426.
25. Dickson DW. Aging in the central nervous system. In: Markesbery WR, editor. Neuropathology of dementing disorders. London: Arnold, 1998. p. 56-88.
26. Dickson D.W. Tau and synuclein and their role in neuropathology. Brain Pathol. 9:1999;657-661.
27. Dickson D.W., Ruan D., Crystal H., Mark M.H., Davies P., Kress Y.et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology. 41:1991;1402-1409.
28. Dickson D.W., Schmidt M.L., Lee V.M.Y., Zhao M.L., Yen S.H., Trojanowski J.Q. Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease. Acta Neuropathol. 87:1994;269-276.
29. Dubois B., Pillon B. Cognitive deficits in Parkinson's disease. J. Neurol. 244:1997;2-8.
30. Duda J.E., Lee V.M.Y., Trojanowski J.Q. Neuropathology of synuclein aggregates: new insights into mechanism of neurodegenerative diseases. J. Neurosci. Res. 61:2000;121-127.
31. Fahn S. Parkinson's disease and other basal ganglion disorders. In: Asbury AK, McKhann GM, McDonald WI, editors. Diseases of the Nervous System: Clinical Neurobiology, vol. 1. Philadelphia: Saunders, 1992. p. 1144-58.
32. Fearnley J, Lees AJ. Pathology of Parkinson's disease. In: Calne DB, editor. Neurodegenerative Diseases. Philadelphia: Saunders, 1991. p. 545-54.
33. Forno L.S. Concentric hyalin intraneuronal inclusions of Lewy type in the brain of elderly persons (50 incidental cases): relationship to parkinsonism. J. Am. Geriatr. Soc. 17:1969;557-575.
34. Forno L.S. Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55:1996;259-272.
35. Gai W.P., Power J.H., Blumbergs P.C., Culvenor J.G., Jensen P.H. Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components. J. Neurochem. 73:1999;2093-2100.
36. Galvin J.E., Lee V.M.Y., Trojanowski J.Q. Synucleinopathies. Clinical and pathological implications. Arch. Neurol. 58:2001;186-190.
37. Geisler M.W., Murphy C. Event-related brain potentials to attended and ignored olfactory and trigeminal stimuli. Int. J. Psychophysiol. 37:2000;309-315.
38. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson's disease. Arch. Neurol. 56:1999;33-39.
39. Gibb W.R.G. Neuropathology of the substantia nigra. Eur. Neurol. 31(Suppl 1):1991;48-59.
40. Gibb W.R.G., Lees A.J. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 54:1991;388-396.
41. Gibb W.R.G., Scott T., Lees A.J. Neuronal inclusions of Parkinson's disease. Mov. Disord. 6:1991;2-11.
42. Goedert M. The significance of tau and α-synuclein inclusions in neurodegenerative diseases. Curr. Opin. Genet. Dev. 11:2001;343-351.
43. Goetz C.G., Luthe W., Tanner C.M. Autonomic dysfunction in Parkinson's disease. Neurology. 36:1986;73-75.
44. Hassler R. Zur Normalanatomie der Substantia nigra. Versuch einer architektonischen Gliederung. J. Psychol. Neurol. 48:1937;1-55.
45. Hassler R. Zur Pathologie der paralysis agitans und des postencephalitischen Parkinsonismus. J. Psychol. Neurol. 48:1938;387-476.
46. Hawkes C.H., Shephard B.C., Daniel S.E. Olfactory dysfunction in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 62:1997;436-5446.
47. Hawkes C.H., Shephard B.C., Daniel S.E. Is Parkinson's disease a primary olfactory disorder? Q. J. Med. 92:1999;473-480.
48. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression, and mortality. Neurology. 17:1967;427-442.
49. Hyman B.T. New neuropathological criteria for Alzheimer's disease. Arch. Neurol. 55:1998;1174-1176.
50. Irizarry M.C., Growdon W., Gómez-Isla T., Newell K., George J.M., Clayton D.F.et al. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J. Neuropathol. Exp. Neurol. 57:1998;334-337.
51. Jellinger K. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol. Chem. Neuropathol. 14:1991;153-197.
52. Koller W.C. When does Parkinson's disease begin? Neurology. 42(Suppl 4):1992;27-31.
53. Korczyn A.D. Autonomic nervous system disturbances in Parkinson's disease. Adv. Neurol. 53:1990;463-468.
54. Lewy FH. Paralysis agitans. I. Pathologische Anatomie. In: Lewandowski M, editor. Handbuch der Neurologie, Band III. Berlin: Springer, 1912. p. 920-33.
55. Lowe J. Lewy bodies. In: Calne DB, editor. Neurodegenerative Diseases. Philadelphia: Saunders, 1994. p. 51-69.
56. Loza A., Pepin J.L., Rapisarda G., Moglia A., Delwaide P.J. Functional changes of brainstem reflexes in Parkinson's disease. Conditioning of blink reflex R2 component by paired and index finger stimulation. J. Neural Transm. 104:1997;679-687.
57. Meco G., Pratesi L., Bonifati V. Cardiovascular reflexes and autonomic dysfunction in Parkinson's disease. J. Neurol. 238:1991;195-199.
58. Mesholam R.L., Moberg P.J., Mahr R.N., Doty R.L. Olfaction in neurodegenerative disease. A meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch. Neurol. 55:1998;84-90.
59. Pearce R.K., Hawkes C.H., Daniel S.E. The anterior olfactory nucleus in Parkinson's disease. Mov. Disord. 10:1995;283-287.
60. Perry R.H., Irving D., Tomlinson B.E. Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei. J. Neurol. Sci. 100:1990;223-233.
61. Pollanen M.S., Dickson D.W., Bergeron C. Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol. 52:1993;183-191.
62. Price JL. Olfactory system. In: Paxinos G, editor. The Human Nervous System. San Diego: Academic Press, 1990. p. 979-1000.
63. Rajput AH. Clinical features and natural history of Parkinson's disease (special consideration of aging). In: Calne DB, editor. Neurodegenerative Diseases. Philadelphia: Saunders, 1994. p. 555-71.
64. Rüb U., Del Tredici K., Schultz C., Ghebremedhin E., de Vos R.A.I., Jansen Steur E.N.H.et al. Parkinson's disease: the thalamic components of the limbic loop are severely impaired by α-synuclein immunopositive inclusion body pathology. Neurobiol. Aging. 23:2002;245-254.
65. Sakuma K., Nakashima K., Takahashi K. Olfactory evoked potentials in Parkinson's disease, Alzheimer's disease and anosmic patients. Psychiatr. Clin. Neurosci. 50:1996;35-40.
66. Sandmann-Keil D., Braak H., Okochi M., Haass C., Braak E. Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson's disease are detectable by an advanced silver-staining technique. Acta Neuropathol. 98:1999;461-464.
67. Sawle G.V. The detection of preclinical Parkinson's disease: what is the role of positron emission tomography? Mov. Disord. 8:1993;271-277.
68. Trojanowski J.Q., Lee V.M.Y. Aggregation of neurofilament and α-synuclein proteins in Lewy bodies - implications for the pathogenesis of Parkinson-disease and Lewy body dementia. Arch. Neurol. 55:1998;151-152.
69. Valls-Solé J. Neurophysiological characterization of parkinsonian syndromes. Neurophysiol. Clin. 30:2000;352-367.
70. Wakabayashi K., Hansen L.A., Masliah E. Cortical Lewy body-containing neurons are pyramidal cells. Laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32. Acta Neuropathol. 89:1995;404-408.
71. Wakabayashi K., Takahashi H., Obata K., Ikuta F. Immunocytochemical localization of synaptic vesicle-specific protein in Lewy body-containing neurons in Parkinson's disease. Neurosci. Lett. 138:1992;237-240.
72. Wolters E.C., Francot C., Bergmans P., Winogrodzka A., Booij J., Berendse H.W.et al. Preclinical (premotor) Parkinson's disease. J. Neurol. 247(Suppl 2):2000;103-109.